Pacira Biosciences, Inc. (PCRX)
26.04
-0.03
(-0.12%)
USD |
NASDAQ |
Dec 31, 13:00
Pacira Biosciences Market Cap: 1.120B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Hologic, Inc. | 16.62B |
| Arcutis Biotherapeutics, Inc. | 3.614B |
| Amicus Therapeutics, Inc. | 4.395B |
| CorMedix, Inc. | 959.65M |
| ADMA Biologics, Inc. | 4.360B |
Market Cap Related Metrics
| PE Ratio | 58.37 |
| PS Ratio | 1.685 |
| Price to Book Value | 1.541 |
| Price to Free Cash Flow | 9.722 |
| Price | 26.04 |
| Earnings Yield | 1.71% |
| Operating PE Ratio | 20.13 |
| Normalized PE Ratio | 35.17 |